Exploring the Metabolic Impact of FLASH Radiotherapy

Febe Geirnaert1, Lisa Kerkhove1, Pierre Montay-Gruel2,3

  • 1Department of Radiotherapy, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, 1090 Brussels, Belgium.

Cancers
|January 11, 2025
PubMed
Summary

FLASH radiotherapy (FLASH RT) uses ultrahigh dose rates (UHDRs) to potentially reduce normal tissue damage while controlling tumors. Research suggests altered metabolic and cellular responses, particularly in reactive oxygen species and mitochondria, underlie this promising cancer treatment effect.